These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6411532

  • 1. Polychemotherapy (COMP) treatment in myeloma patients. A preliminary report.
    Izzi T, Polchi P, Moretti L, Lucarelli G.
    Haematologica; 1983; 68(3):381-91. PubMed ID: 6411532
    [No Abstract] [Full Text] [Related]

  • 2. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y, Karitani Y, Tanaka I, Kobayashi T, Ohno T, Kageyama S, Katayama N, Kataoka Y, Kamio N, Ohota C.
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N, Lurie P, Mietlowski WL, Schilling A, Bennett JM, Horton J.
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Survival and therapy of multiple myeloma. Apropos of 56 observed cases].
    Locatelli F, Giovanelli E, Neretto G, Furno F, Pellerito R.
    Minerva Med; 1979 Mar 17; 70(13):925-33. PubMed ID: 220567
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of modalities in soft tissue sarcomas.
    Karakousis CP.
    Int Adv Surg Oncol; 1982 Mar 17; 5():91-113. PubMed ID: 6896509
    [No Abstract] [Full Text] [Related]

  • 12. [Recent progress in chemotherapy of multiple myeloma].
    Tortarolo M, Cantore N, Russolillo S, Castaldo C, Buonanno G.
    Recenti Prog Med; 1978 Jul 17; 65(1):44-68. PubMed ID: 370935
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthy PL, Alam AR.
    Bone Marrow Transplant; 2002 Apr 17; 29(7):577-80. PubMed ID: 11979306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma].
    Wutke K, Anger G.
    Z Gesamte Inn Med; 1983 Dec 01; 38(23):630-3. PubMed ID: 6689459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.